{"id":"W4402766756","doi":"10.1016/j.eclinm.2024.102838","title":"Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable","year":2024,"lang":"en","type":"review","venue":"EClinicalMedicine","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Canada","funders":"Janssen Pharmaceuticals; National Institute for Health Research Applied Research Collaboration West; MSD K.K.; Genentech; Chugai Pharmaceutical; Agency for Healthcare Research and Quality; Centers for Disease Control and Prevention; National Institutes of Health; Shionogi; Astellas Pharma; Eisai; Cancer Research UK; National Eye Institute; Seagen; National Institute for Health and Care Research; Medical Research Council; Verily Life Sciences; Department of Health and Social Care; MacroGenics; Imperial Experimental Cancer Medicine Centre; Anthony Nolan; Massachusetts Medical Society; Sarcoma UK; National Cancer Institute; Gilead Sciences; Yale University; GlaxoSmithKline; UK Research and Innovation; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Amgen; Birmingham Biomedical Research Centre; Pfizer; Astex Pharmaceuticals; Pfizer Pharmaceuticals; American Heart Association","keywords":"Medicine; Tolerability; Clinical trial; Patient care; Phase (matter); Medical physics; Intensive care medicine; Alternative medicine; Nursing; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05855528,0.001038148,0.01604966,0.0009203498,0.0002124184,0.0002991332,0.0006548685,0.001202415,0.00017747],"category_scores_gemma":[0.1128916,0.00088044,0.002050754,0.0006571597,0.0001486663,0.0009502353,0.0002325596,0.002060076,0.0001710179],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003701664,"about_ca_system_score_gemma":0.002081431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002907786,"about_ca_topic_score_gemma":0.0006290458,"domain_scores_codex":[0.9438161,0.006123409,0.04584294,0.002927705,0.0003961497,0.0008937359],"domain_scores_gemma":[0.9394757,0.04005539,0.01714224,0.002183501,0.0002801339,0.0008630782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001925075,0.003752337,0.01325718,0.008457978,0.001790971,0.00007692254,0.007769065,0.00001651226,7.897397e-8,0.004818432,0.01328423,0.9465838],"study_design_scores_gemma":[0.005699032,0.003508416,0.0004303948,0.01120231,0.0006393525,0.000004073639,0.003110394,0.001612395,6.791289e-8,0.003146979,0.9695983,0.001048277],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0173651,0.9529506,0.004728157,0.00358776,0.01110192,0.00846439,0.001493042,0.0001541396,0.0001548972],"genre_scores_gemma":[0.007253267,0.9640293,0.009889451,0.007541565,0.004074174,0.003292464,0.003451489,0.0002957801,0.0001724807],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9563141,"threshold_uncertainty_score":0.9993646,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6343121863443338,"score_gpt":0.629434758257566,"score_spread":0.004877428086767832,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}